Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC)

SIMPLE SUMMARY: Each year, new cases of oral cancer occur and metastasis represents the primary determinant for survival. Thus, there is a need to improve the preoperative assessment of metastatic risk. Scientific evidence discovered that BAY 11-7082, a powerful inhibitor of the NLRP3 inflammasome,...

Descripción completa

Detalles Bibliográficos
Autores principales: Casili, Giovanna, Scuderi, Sarah Adriana, Lanza, Marika, Filippone, Alessia, Mannino, Deborah, Giuffrida, Raffaella, Colarossi, Cristina, Mare, Marzia, Capra, Anna Paola, De Gaetano, Federica, Portelli, Marco, Militi, Angela, Cuzzocrea, Salvatore, Paterniti, Irene, Esposito, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216277/
https://www.ncbi.nlm.nih.gov/pubmed/37345134
http://dx.doi.org/10.3390/cancers15102796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216277/
https://www.ncbi.nlm.nih.gov/pubmed/37345134
http://dx.doi.org/10.3390/cancers15102796

Ejemplares similares